ArticleJTCVS open2023

Rivaroxaban versus warfarin in postoperative atrial fibrillation: Cost-effectiveness analysis in a single-center, randomized, and prospective trial.

Marcel de Paula Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.